taiheng-凯发平台

about us

shanghai tai heng industry group co., ltd was founded in 1995. it is a pharmaceutical enterprise in the stage of vigorous development. the company has developed an efficient young team dedicated to product development, quality management, regulation registration and market development. our r & d and production strictly follow the requirements of us fda and ich to provide the global customers with the necessary pharmaceutical products and technical support.

news

12/03 2021

tai heng official notice

in order to meet our rapid development needs, our new r&d center in minhang district, shanghai will be operational i...

09/18 2021

dmf of tai heng’s fingolimod hydrochloride api product has successfully passed the review by us fda

on september 14, 2021, tai heng received an official letter from the us fda regarding the product dmf (#028142) of fingo...

05/14 2019

tai heng submitted a us dmf on a client’s commission and the dmf has passed fda administrative review

tai heng submitted the dmf of an undisclosed api product to us fda in behalf of one of our chinese client, and received ...

12/21 2018

best wishes on this holiday season

执行时间：0.028563976287842秒查询数据库3次内存使用：1.279 mb - 385.453 kb = 924.703 kb 当前模式：developer